BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• In Line With the Business Plan Presented at the IPO, ASIT Biotech Prepares an Additional Fund Raising to Further Develop its Products

  The new shares will be issued without a discount on the average share price of the last 30 days preceding the issue of the new shares.

  November 8, 2017

   · 

  12 min read
• Business

  Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants

  Exchange offer to expire one minute after 11:59 p.m., New York City time, on November 13, 2017, unless extended.

  November 8, 2017

   · 

  10 min read
• Business

  Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram

  Ingram’s decision to resign as a director from the Company’s Board of Directors effective November 6, 2017 is due to his appointment as President and CEO of Sarepta Therapeutics earlier this year.

  November 8, 2017

   · 

  4 min read
• Business

  Novus Therapeutics Reports Third Quarter 2017 Results

  For the third quarter of 2017, Novus reported a net loss of $3.0 million, or $0.43 loss per share, compared to a net loss of $2.0 million, or $4.35 loss per share, for the same period in 2016.

  November 8, 2017

   · 

  16 min read
• Drug Development

  vTv Therapeutics Initiates Phase 1b/2 Study Evaluating TTP399 for the Treatment of Type 1 Diabetes

  Results from the Phase1b part of the study are expected in early 2018.

  November 8, 2017

   · 

  6 min read
• Business

  ViewRay Announces Conference Call and Webcast of Third Quarter 2017 Financial Results to be Held on November 13, 2017

  ViewRay will hold a conference call on Monday, November 13, 2017 at 8:30 a.m. ET / 5:30 a.m. PT to discuss the results.

  November 8, 2017

   · 

  1 min read
• Business

  Phagelux Announces a Multi-Product Collaboration With Passport Food Safety Solutions

  Phagelux’s U.S. operating division has entered into an agreement to develop for Passport Food Safety four bacteriophage-based products to be used for a variety of food safety and environment protection purposes.

  November 8, 2017

   · 

  2 min read
• Business

  Aeterna Zentaris Reports Third Quarter 2017 Financial and Operating Results

  Revenues were $241,000 and $745,000 for the three and nine months ended September 30, 2017, as compared to $269,000 and $607,000 for the same periods in 2016.

  November 8, 2017

   · 

  13 min read
• Lone Star Bio

  DisperSol Technologies Announces New R&D Data to Be Presented at 2017 Annual Meeting of AAPS

  The symposium will highlight partners’ experiences with KinetiSol: a novel manufacturing technology for making amorphous solid dispersions of poorly water-soluble drug molecules to enhance their bioavailability & clinical effectiveness.

  November 8, 2017

   · 

  2 min read
• 

  FDA

  DT MedTech Wins FDA Nod for Hintermann Series H2 Total Ankle Replacement System

  The Hintermann Series H2 is a semi-constrained, total ankle replacement prosthesis developed by a world-renowned foot and ankle surgeon based in Switzerland.

  November 8, 2017

   · 

  3 min read